GURUFOCUS.COM » STOCK LIST » USA » NYSE » Alcon Inc (NYSE:ALC) » Definitions » Debt-to-Equity
Switch to:

Alcon Debt-to-Equity

: 0.22 (As of Jun. 2022)
View and export this data going back to 2019. Start your Free Trial

Alcon's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $152 Mil. Alcon's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2022 was $4,227 Mil. Alcon's Total Stockholders Equity for the quarter that ended in Jun. 2022 was $19,541 Mil. Alcon's debt to equity for the quarter that ended in Jun. 2022 was 0.22.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Alcon's Debt-to-Equity or its related term are showing as below:

ALC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.23   Max: 0.24
Current: 0.22

During the past 6 years, the highest Debt-to-Equity Ratio of Alcon was 0.24. The lowest was 0.01. And the median was 0.23.

ALC's Debt-to-Equity is ranked worse than
52.12% of 683 companies
in the Medical Devices & Instruments industry
Industry Median: 0.20 vs ALC: 0.22

Alcon Debt-to-Equity Historical Data

The historical data trend for Alcon's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alcon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-Equity
Premium Member Only 0.01 0.01 0.20 0.24 0.23

Alcon Quarterly Data
Dec16 Dec17 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.24 0.23 0.23 0.22

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Alcon's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Alcon Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Alcon's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Alcon's Debt-to-Equity falls into.



Alcon Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Alcon's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Alcon's Debt to Equity Ratio for the quarter that ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alcon  (NYSE:ALC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Alcon Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Alcon's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Alcon Business Description

Alcon logo
Traded in Other Exchanges
Address
Chemin de Blandonnet 8, Royce Bedward, Vernier, Geneva, CHE, 1214
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.

Alcon Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)